文献速递瓣膜外科

术前风险分层与二尖瓣置换术后长期生存

Long-Term Survival After Mitral Valve Replacement by Preoperative Risk: Implications for Patient Selection.
PubMed 文献 · Ann Thorac Surg · 2025-08-14

单中心2010—2023年855例孤立二尖瓣置换患者按STS预测死亡风险(PROM)分为低(<3%)、中(3%—6%)、高/极高(>6%)三组,比较30天与5年生存。5年生存率分别为90.8%、75.5%、56.4%,组间差异显著(P < .001);术前透析、高血压、急诊手术与更差长期生存相关。

要点

  • STS PROM与孤立二尖瓣置换术后5年死亡率相关,可用于长期风险分层
  • 高危组30天实际死亡率(10.9%)低于预测,提示高容量中心可能高估手术风险
  • 术前透析、高血压、急诊手术状态与更差长期生存独立相关

核心结论

  • 尽管预测模型可能高估高容量二尖瓣中心的手术风险,STS PROM仍与孤立MVR的5年死亡率相关,可提供更具体的风险分层标准以筛选适合手术的患者。

研究设计与样本

  • 单中心回顾性研究,纳入2010—2023年高容量二尖瓣参考中心行孤立MVR的患者855例(总MVR 1444例)。
  • 按STS PROM分层:低危<3%、中危3%—6%、高危/极高危>6%。
  • 主要终点为30天与5年死亡率,采用Kaplan-Meier生存分析及Cox回归模型。

主要发现

  • 低、中、高危组平均STS PROM分别为1.7%、4.3%、12.7%。
  • 30天死亡率:低危组0.3%、高危/极高危组10.9%,均低于预测。
  • 5年生存率分别为90.8%、75.5%、56.4%,Kaplan-Meier分析显示组间长期生存概率差异显著(P < .001)。
  • 术前透析(HR 1.70;95%CI 1.05-2.73;P = .03)、高血压(HR 1.71;95%CI 1.13-2.59;P = .011)、急诊手术状态(HR 1.57;95%CI 1.09-2.26;P = .02)与更差长期生存相关。

关键数值与推荐

  • 风险分层阈值:低危STS PROM<3%,中危3%—6%,高危/极高危>6%。
  • 5年生存率:低危90.8%、中危75.5%、高危/极高危56.4%(P < .001)。
  • 与更差长期生存相关的因素:术前透析HR 1.70(95%CI 1.05-2.73;P = .03)、高血压HR 1.71(95%CI 1.13-2.59;P = .011)、急诊手术HR 1.57(95%CI 1.09-2.26;P = .02)。

临床怎么用

  • 可将STS PROM用于孤立MVR患者的长期风险沟通与术前分层,而不仅限于30天手术风险。
  • 在高容量中心,高危/极高危患者实际短期死亡率可能低于模型预测,不应仅凭PROM>6%排除手术。
  • 合并术前透析、高血压或需急诊手术者应纳入长期随访与围术期优化重点。

局限性

  • 单中心回顾性研究,结果外推需谨慎。
  • 仅纳入孤立MVR患者,未涵盖合并其他手术者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mitral valve replacement (MVR) is recognized for its significant operative risks. This risk is commonly quantified with The Society of Thoracic Surgeons (STS) Risk Calculator. The present study aimed to investigate the long-term (5-year) predictive capabilities of the STS predicted risk of mortality (PROM) in patients undergoing isolated MVR. METHODS: Patients undergoing isolated MVR at a high-volume mitral reference center from 2010-2023 were stratified by STS PROM (low: <3%, intermediate: 3%-6%, and high/extreme: >6%). Primary endpoints were short-term (30-day) and long-term (5-year) mortality. Kaplan-Meier survival analysis was used to compare short- and long-term survival among risk stratified groups. Cox regression modeling was used to identify predictors of long-term survival. RESULTS: Of 1444 of MVR patients, 855 patients underwent isolated MVR. The mean STS PROM for low, intermediate, and high/extreme-risk groups was 1.7%, 4.3%, and 12.7%, respectively. Thirty-day mortality was lower than predicted in the low (0.3%) and high/extreme risk (10.9%) groups. Five-year survival was 90.8%, 75.5%, and 56.4% respectively. Kaplan-Meier survival analysis at 5 years identified significant long-term survival probability differences among the PROM groups, even after accounting for perioperative risk (P < .001). Preoperative dialysis (hazard ratio [HR], 1.70; 95% CI 1.05-2.73; P = .03), hypertension (HR, 1.71; 95% CI, 1.13-2.59; P = .011), and urgent operative status (HR, 1.57; 95% CI, 1.09-2.26; P = .02) were among the characteristics associated with worse long-term survival. CONCLUSIONS: Although predictive models may overestimate surgical risk at high-volume mitral centers, the STS PROM correlates with 5-year mortality in isolated MVR. These findings may provide more specific risk stratification criteria, identifying patients best suited for operative intervention.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kazaleh M, Wagner C, Pegues J, et al. Long-Term Survival After Mitral Valve Replacement by Preoperative Risk: Implications for Patient Selection. Ann Thorac Surg. 2025. PMID: 40818635. doi:10.1016/j.athoracsur.2025.07.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。